Harris & Harris Group to Hold "Meet the Portfolio" Day - Healthcare on May 7, 2010
NEW YORK, April 7, 2010 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY) will hold its second "Meet the Portfolio" Day on Friday, May 7, 2010, at the NASDAQ MarketSite (4 Times Square, 43rd Street & Broadway) in New York City. The event, to begin at 8:00 a.m. ET, will feature healthcare companies in Harris & Harris Group's portfolio.
Harris & Harris Group welcomes professional money managers, securities analysts and strategic partners to attend the event and hear directly from the CEOs of its portfolio companies about their work and commercial progress.
Presentation Schedule
---------------------------------------------------------------
Time (ET) Company Website
------------- ------------------------- ---------------------
8:00 AM Coffee
------------- ------------------------- ---------------------
Harris & Harris Group --
8:30 AM Introductory Remarks www.hhvc.com
------------- ------------------------- ---------------------
9:00 AM Orthovita (Nasdaq:VITA) www.orthovita.com
------------- ------------------------- ---------------------
NASDAQ Opening Bell
9:20 AM Ceremony
------------- ------------------------- ---------------------
www.ensemblediscovery
9:30 AM Ensemble Discovery .com
------------- ------------------------- ---------------------
9:50 AM Metabolon www.metabolon.com
------------- ------------------------- ---------------------
10:10 AM Ancora Pharmaceuticals www.ancorapharma.com
------------- ------------------------- ---------------------
10:30 AM PolyRemedy www.polyremedy.com
------------- ------------------------- ---------------------
10:50 AM Enumeral Technologies NA
------------- ------------------------- ---------------------
11:10 AM Solazyme www.solazyme.com
------------- ------------------------- ---------------------
11:30 AM Mersana Therapeutics www.mersana.com
------------- ------------------------- ---------------------
11:50 AM BioVex www.biovex.com
------------- ------------------------- ---------------------
Harris & Harris Group --
12:10 PM Closing Remarks www.hhvc.com
------------- ------------------------- ---------------------
12:20 PM Lunch
------------- ------------------------- ---------------------
For those who are unable to attend in person, live and archived webcasts of the presentations will be available on the Company's website (www.hhvc.com). For additional information, contact Marisa Whitlock of Harris & Harris Group at 650-321-2668 or marisa@hhvc.com.
Harris & Harris Group is a publicly traded venture capital company that invests in nanotechnology and microsystems. Detailed information about Harris & Harris Group and its holdings, including articles on nanotechnology, cleantech and venture capital, can be found on its website at www.HHVC.com.
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the year ended December 31, 2009, as well as subsequent SEC filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the website www.HHVC.com has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.
CONTACT: Harris & Harris Group
Douglas W. Jamison, Chairman and Chief Executive Officer
(212) 582-0900
Lippert Heilshorn & Associates
Investor Contact:
Harriet Fried
Jody Burfening
(212) 838-3777
Released April 7, 2010